[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634219":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":32,"responsibleParty":56,"collaborators":10,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":10,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":79,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Military Medical Clinical Center of the Southern Region, Ukraine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"AIP Suspected Cohort",null,"Patients evaluated for suspected autoimmune pancreatitis. Participants undergo standard clinical, serological, imaging, and histological assessment according to the Odesa Criteria 2026 (OC26). No interventions are assigned as this is an observational study.",[13],"Other: No intervention (observational study)",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"No intervention (observational study)","Participants receive no assigned intervention. Diagnostic evaluation follows routine clinical practice.",[9],[20],{"name":21,"affiliation":22,"role":23},"Oleg Dovbenko","Odesa Regional Clinical Medical Center","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Oleg Dovbenko, MD, PhD","CONTACT","+380682539685","dovbenko2015@hotmail.com",{"name":26,"role":27,"phone":28,"phoneExt":10,"email":31},"dovbenko73@gmail.com",[33,49],{"facility":34,"status":35,"city":36,"state":10,"zip":10,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Military Medical Clinical Center of the Southern Region","RECRUITING","Odesa","Ukraine","UA",{"type":40,"coordinates":41},"Point",[42,43],30.74383,46.48572,{"lat":43,"lon":42},[46],{"name":47,"role":27,"phone":48,"phoneExt":10,"email":29},"Oleh Dovbenko, MD, PhD","0682539685",{"facility":34,"status":35,"city":36,"state":10,"zip":10,"country":37,"countryCode":38,"cosmosGeoPoint":50,"geoPoint":52,"contacts":53},{"type":40,"coordinates":51},[42,43],{"lat":43,"lon":42},[54,55],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":26,"role":27,"phone":28,"phoneExt":10,"email":31},{"type":23,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Oleg Dovbenko, MD","Head of Endoscopic Surgery Department","100634219","validation-of-the-odesa-criteria-2026-for-autoimmune-pancreatitis-100634219",false,"NCT07536841","Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis","Validation of the Odesa Criteria 2026 (OC26) for the Diagnosis of Autoimmune Pancreatitis","ОС26","Inclusion Criteria:\n\n* Adults (≥18 years) undergoing evaluation for suspected autoimmune pancreatitis.\n* Availability of clinical, serological, imaging, and\u002For histological data required for OC26 scoring.\n* Ability to provide informed consent (for prospective participants).\n\nExclusion Criteria:\n\n* Confirmed alternative diagnosis explaining pancreatic findings (e.g., pancreatic cancer, acute pancreatitis of other etiology).\n* Incomplete diagnostic data preventing OC26 scoring.\n* Prior pancreatic surgery altering diagnostic interpretation.","ALL","18 Years",{"count":70,"type":71},82,"ESTIMATED","OBSERVATIONAL","This ambispective observational study aims to validate the Odesa Criteria 2026 (OC26), a flexible domain-based point scoring system for diagnosing autoimmune pancreatitis. The study evaluates diagnostic accuracy and reproducibility of OC26 across clinical, serological, morphological, and histological domains.",[75,76,77,78],"Autoimmune Pancreatitis","IgG4-Related Diseases","Pancreatic Cancer","Chronic Pancreatitis",[80,81,82,83,84,85,86,87,88],"AIP","IgG4","Autoimmune pancreatitis diagnosis","Pancreatic imaging","Endoscopic ultrasound","Serum protein fractions","IgG6\u002FIgG8 ratio","Odesa Criteria 2026 (OC26)","EUS Doppler","2026-05-23",{"date":91,"type":92},"2026-05-28","ACTUAL",{"date":94,"type":92},"2026-05-01",{"date":96,"type":71},"2026-12-01",{"name":5,"class":6},2]